However, the inhibition of the PI3K/Akt/mTOR pathway by small-molecule PI3K inhibitors primes cancer cells to mitochondrial apoptosis by tipping the balance toward proapoptotic Bcl-2 proteins, resulting in increased mitochondrial outer membrane permeabilization. This evidence concerns the gene MTOR and cancer.